Virtual Medicinal Product (VMP)
-
Fluticasone propionate 50micrograms/dose dry powder inhaler
Name Details
Current Name
Fluticasone propionate 50micrograms/dose dry powder inhaler
|
Start Date
01-01-2014
|
End Date
|
Previous Name
Fluticasone 50micrograms/dose dry powder inhaler
|
Start Date
16-08-2006
|
End Date
31-12-2013
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- dose
- Unit Dose UOM
- dose
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Inhalation
- Form
- Inhalation powder
- Ontology Form/Route
- powderinhalation.inhalation
- Name Basis
- INNM - International Non-proprietary Name (Modified)
Codes
- ATC Code
-
R03BA05
BNF |
Current BNF
03020000
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
03020000
|
Start Date
01-02-2005
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
38897911000001106 |
19-08-2020 |
|
320602002 |
16-12-2002 |
18-08-2020 |
VMP Ingredients
Name
Fluticasone propionate
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
50
Strength and UOM (Dmr)
1
Parent Products
-
VTM
Fluticasone
-
VMP
(Current) Fluticasone propionate 50micrograms/...
Virtual Medicinal Product Pack (VMPP) Information